The Role of PD-1 (PDCD1) Promoter Methylation (mPDCD1) in Merkel Cell Carcinoma

Key Points

• Increased PD-1 promoter methylation correlates with altered immune responses in Merkel cell carcinoma.
• Key evidence includes findings from previous studies suggesting a significant link between mPDCD1 levels and tumor progression.
• Observational analysis explores the connection between PD-1 methylation and immune evasion in Merkel cell carcinoma.
• Highlights the need for further studies to validate PD-1 methylation as a reliable biomarker in clinical settings.

Abstract